2252
Luo and Anderson
effects of fructose, glucose, and xylose as the reducing sugar. J. 25. P.-S. K. Leung and M. R. Hoffmann. Kinetics and mechanism of
the oxidation of 2-mercaptoethanol by hydrogen peroxide in
Agric. Food Chem. 50:7034 Y7041 (2002).
3. S. P. Duddu and K. Weller. Importance of glass transition
aqueous solution. J. Phys. Chem. 89:5267 Y5271 (1985).
temperature in accelerated stability testing of amorphous solids: 26. C. C. Winterbourn and D. Metodewa. Reactivity of biologically
case study using a lyophilized aspirin formulation. J. Pharm. Sci.
85:345Y347 (1996).
4. K. A. Connors. Chemical Kinetics. The Study of Reaction Rates 27. J. P. Barton, J. E. Packer, and R. J. Sims. Kinetics of the reaction
important thiol compounds with superoxide and hydrogen
peroxide. Free Radic. Biol. Med. 27:322 Y328 (1999).
in Solution, VCH, New York, NY, 1990.
5. S. Yoshioka and V. J. Stella. Stability of Drugs and Dosage
Forms, Kluwer, New York, NY, 2000.
6. B. C. Hancock and M. Parks. What is the true solubility
advantage of amorphous pharmaceuticals?. Pharm. Res.
17:397Y 404 (2000).
7. A. A. Ambike, K. R. Mahadik, and A. Paradkar. Spray-dried
amorphous solid dispersions of simvastatin, a low Tg drug:
in vitro and in vivo evaluations. Pharm. Res. 22:990Y998 (2005).
8. J. E. Carpenter, M. J. Pikal, B. S. Chang, and T. W. Randolph.
of hydrogen peroxide with cysteine and cysteamine. J. Chem.
Soc., Perkin Trans. II 1973:1547Y1549 (1973).
28. D. Luo, S. W. Smith, and B. D. Anderson. Kinetics and
mechanism of the reaction of cysteine and hydrogen peroxide
in aqueous solution. J. Pharm. Sci. 94:304 Y316 (2005).
29. Y. H. Zhao, M. H. Abraham, and A. M. Zissimos. Determina-
tion of McGowan volumes for ions and correlation with van der
Waals volumes. J. Chem. Inf. Comput. Sci. 43:1848 Y1854 (2003).
30. C. W. Jones. Applications of Hydrogen Peroxide and Deriva-
tives, Royal Society of Chemistry, Cambridge, UK, 1999.
Rational design of stable lyophilized protein formulations: some 31. B. S. Chang and C. S. Randall. Use of subambient thermal
practical advice. Pharm. Res. 14:969Y975 (1997).
9. J. F. Carpenter, K.-I. Izutsu, and T. W. Randolph. Freezing- and
analysis to optimize protein lyophilization. Cryobiology 29:
632 Y656 (1992).
drying-induced perturbations of protein structure and mech- 32. L. S. Taylor, F. W. Langkilde, and G. Zografi. Fourier transform
anisms of protein protection by stabilizing additives. In L. raman spectroscopic study of the interaction of water vapor with
Rey and J. C. May (eds.), Drugs Pharm. Sci., 96 (Freeze-Drying/ amorphous polymers. J. Pharm. Sci. 90:888 Y901 (2001).
Lyophilization of Pharmaceutical and Biological Products, 33. T. Huang, M. E. Garceau, and P. Gao. Liquid chromatographic
Marcel Dekker, New York, 1999, p 123.
determination of residual hydrogen peroxide in pharmaceutical
excipients using platinum and wired enzyme electrodes. J.
Pharm. Biomed. Anal. 31:1203 Y1210 (2003).
10. F. Franks, R. H. M. Hatley, and S. F. Mathias. Materials science
and the production of shelf-stable biologicals. Pharm. Technol.
March:32Y50 (1992).
11. C. Ahlneck and G. Zografi. The molecular basis of moisture
effects on the physical and chemical stability of drugs in the solid
state. Int. J. Pharm. 62:87Y95 (1990).
12. Y. Aso, S. Yoshioka, J. Zhang, and G. Zografi. Effect of water
on the molecular mobility of sucrose and poly(vinylpyrrolidone)
in a colyophilized formulation as measured by 13C-NMR
relaxation time. Chem. Pharm. Bull. 50:822Y826 (2002).
13. Y. Guo, S. R. Byrn, and G. Zografi. Physical characteristics and
chemical degradation of amorphous quinapril hydrochloride. J.
Pharm. Sci. 89:128 Y143 (2000).
14. B. C. Hancock, S. L. Shamblin, and G. Zografi. Molecular
mobility of amorphous pharmaceutical solids below their glass
transition temperatures. Pharm. Res. 12:799 Y806 (1995).
34. C. Vignaud, L. Rakotozafy, A. Falguieres, J. Potus, and J.
Nicolas. Separation and identification by gel filtration and high-
performance liquid chromatography with UV or electrochemical
detection of the disulphides produced from cysteine and
glutathione oxidation. J. Chromatog. A 1031:125 Y133 (2004).
35. R. Kohlrausch. Theorie des electrischen Ru¨ckstandes in der
Leidner Flasche. Pogg. Ann. Phys. Chem. 91:179 Y214 (1854).
36. G. Williams and D. C. Watts. Non-symmetrical dielectric
relaxation behavior arising from a simple empirical decay
function. Trans. Faraday Soc. 66:80 Y85 (1970).
37. G. Williams, D. C. Watts, S. B. Dev, and A. M. North. Further
considerations of non symmetrical dielectric relaxation behav-
iour arising from a simple empirical decay function. Trans.
Faraday Soc. 67:1323 Y1335 (1971).
15. B. C. Hancock and G. Zografi. Characteristics and significance 38. T. Geiger and S. Clarke. Deamidation, isomerization, and
of the amorphous state in pharmaceutical systems. J. Pharm. Sci.
86:1 Y12 (1997).
16. C. A. Oksanen and G. Zografi. Molecular mobility in mixtures
racemization at asparaginyl and aspartyl residues in peptides.
Succinimide-linked reactions that contribute to protein degra-
dation. J. Biol. Chem. 262:785 Y794 (1987).
of absorbed water and solid poly(vinylpyrrolidone). Pharm. Res. 39. R. T. Darrington and B. D. Anderson. Evidence for a common
10:791 Y799 (1993).
intermediate in insulin deamidation and covalent dimer forma-
tion: effects of pH and aniline trapping in dilute acidic solutions.
J. Pharm. Sci. 84:275 Y282 (1995).
17. E. Y. Shalaev and G. Zografi. How does residual water affect
the solid-state degradation of drugs in the amorphous state?. J.
Pharm. Sci. 85:1137 Y1141 (1996).
18. C. A. Angell. Formation of glasses from liquids and biopol-
ymers. Science 267:1924 Y1935 (1995).
19. T.-X. Xiang and B. D. Anderson. A molecular dynamics
simulation of reactant mobility in an amorphous formulation of
a peptide in poly(vinylpyrrolidone). J. Pharm. Sci. 93:855 Y876
(2004).
20. Y. Gebremichael, T. B. Schroder, F. W. Starr, and S. C. Glotzer.
Spatially correlated dynamics in a simulated glass-forming
40. R. G. Strickley and B. D. Anderson. Solid-state stability of
human insulin I. Mechanism and the effect of water on the
kinetics of degradation in lyophiles from pH 2-5 solutions.
Pharm. Res. 13:1142 Y1153 (1996).
41. R. G. Strickley and B. D. Anderson. Solid-state stability of
human insulin. II. Effect of water on reactive intermediate
partitioning in lyophiles from pH 2Y5 solutions - stabilization
against covalent dimer formation. J. Pharm. Sci. 86:645 Y653
(1997).
polymer melt: analysis of clustering phenomena. Phys. Rev. E 42. H. R. Costantino, R. Langer, and A. M. Klibanov. Aggregation
64:051503-1-13 (2001).
of a lyophilized pharmaceutical protein, recombinant human
albumin: effect of moisture and stabilization by excipients.
Biotechnology 13:493 Y496 (1995).
21. W. Jin and R. H. Boyd. Time evolution of dynamic heteroge-
neity in a polymeric glass: A molecular dynamics simulation
study. Polymer 43:503 Y507 (2002).
22. S. A. Hill, W. MacNaughtan, I. A. Farhat, T. R. Noel, R. Parker,
S. G. Ring, and M. J. Whitcomb. The effect of thermal history
43. D. B. Volkin and A. M. Klibanov. Thermal destruction
processes in proteins involving cystine residues. J. Biol. Chem.
262:2945 Y2950 (1987).
on the Maillard reaction in a glassy matrix. J. Agric. Food Chem. 44. S. E. Zale and A. M. Klibanov. Why does ribonuclease
irreversibly inactivate at high temperatures?. Biochem. 25:
5432 Y5444 (1986).
53:10213 Y10218 (2005).
23. T. W. Randolph. Phase separation of excipients during lyophi-
lization: effects on protein stability. J. Pharm. Sci. 86:1198 Y1203 45. Z. Qiu, J. G. Stowell, K. R. Morris, S. R. Byrn, and R. Pinal.
(1997).
24. T.-X. Xiang and B. D. Anderson. Distribution and effect of
Kinetic study of the Maillard reaction between metoclopramide
hydrochloride and lactose. Int. J. Pharm. 303:20 Y30 (2005).
water content on molecular mobility in poly(vinylpyrrolidone) 46. S. W. Griffiths, J. King, and C. L. Cooney. The reactivity and
glasses:
22:1205 Y1214 (2005).
a
molecular dynamics simulation. Pharm. Res.
oxidation pathway of cysteine 232 in recombinant human a1-
antitrypsin. J. Biol. Chem. 277:25486 Y25492 (2002).